• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默型痴呆中的血清素受体变化

Serotonin receptor changes in dementia of the Alzheimer type.

作者信息

Cross A J, Crow T J, Ferrier I N, Johnson J A, Bloom S R, Corsellis J A

出版信息

J Neurochem. 1984 Dec;43(6):1574-81. doi: 10.1111/j.1471-4159.1984.tb06081.x.

DOI:10.1111/j.1471-4159.1984.tb06081.x
PMID:6208336
Abstract

Serotonin receptors were assessed in post-mortem brains of control and Alzheimer-type dementia (ATD) patients using ligand binding techniques. Differential losses of serotonin S1 and S2 receptors were present in neocortex, hippocampus, and amygdala of ATD patients, whereas no significant changes were observed in basal forebrain and basal ganglia. Losses of S1 receptors were significantly age-related in the ATD group, suggesting they occurred at a later stage of the disease process. Losses of S2 receptors were considerably greater (with a reduction to 35% of control in temporal cortex) and were not age-related in ATD. Significant correlations were observed within the ATD group between S2 receptor binding and somatostatin immunoreactivity in temporal and frontal cortices. Thus the loss of S2 receptors in ATD may be a relatively early change in the disease process, and may precede the changes in ascending serotonergic neurones.

摘要

采用配体结合技术对对照组和阿尔茨海默型痴呆(ATD)患者的尸检大脑中的5-羟色胺受体进行了评估。ATD患者的新皮质、海马体和杏仁核中存在5-羟色胺S1和S2受体的差异性丢失,而在基底前脑和基底神经节中未观察到显著变化。ATD组中S1受体的丢失与年龄显著相关,表明它们发生在疾病进程的后期。S2受体的丢失程度更大(颞叶皮质中降至对照组的35%),且在ATD中与年龄无关。在ATD组中,颞叶和额叶皮质的S2受体结合与生长抑素免疫反应性之间存在显著相关性。因此,ATD中S2受体的丢失可能是疾病进程中相对较早的变化,可能先于上行5-羟色胺能神经元的变化。

相似文献

1
Serotonin receptor changes in dementia of the Alzheimer type.阿尔茨海默型痴呆中的血清素受体变化
J Neurochem. 1984 Dec;43(6):1574-81. doi: 10.1111/j.1471-4159.1984.tb06081.x.
2
Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides.阿尔茨海默型痴呆、抑郁症患者及自杀者大脑中的神经递质受体和单胺代谢产物。
Neuropharmacology. 1984 Dec;23(12B):1561-9. doi: 10.1016/0028-3908(84)90100-x.
3
[3H]ketanserin (serotonin type 2) binding increases in rat cortex following basal forebrain lesions with ibotenic acid.用鹅膏蕈氨酸损毁大鼠基底前脑后,[3H]酮色林(5-羟色胺2型)结合在大鼠皮层中增加。
J Neurochem. 1986 Sep;47(3):845-50. doi: 10.1111/j.1471-4159.1986.tb00688.x.
4
The selectivity of the reduction of serotonin S2 receptors in Alzheimer-type dementia.阿尔茨海默型痴呆中5-羟色胺S2受体减少的选择性。
Neurobiol Aging. 1986 Jan-Feb;7(1):3-7. doi: 10.1016/0197-4580(86)90019-9.
5
Studies on neurotransmitter receptor systems in neocortex and hippocampus in senile dementia of the Alzheimer-type.阿尔茨海默型老年痴呆症新皮质和海马体中神经递质受体系统的研究。
J Neurol Sci. 1984 May;64(2):109-17. doi: 10.1016/0022-510x(84)90029-7.
6
Neurotransmitter changes in early- and late-onset Alzheimer-type dementia.早发型和晚发型阿尔茨海默病型痴呆中的神经递质变化
Prog Neuropsychopharmacol Biol Psychiatry. 1992;16(6):883-90. doi: 10.1016/0278-5846(92)90106-o.
7
Morphological and biochemical changes in the cholinergic and monoaminergic systems in Alzheimer-type dementia.阿尔茨海默型痴呆中胆碱能和单胺能系统的形态学及生化变化。
Acta Neuropathol. 1986;70(2):112-6. doi: 10.1007/BF00691428.
8
Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy.额颞叶痴呆中血清素能系统的失衡:对药物治疗的启示。
Psychopharmacology (Berl). 2008 Mar;196(4):603-10. doi: 10.1007/s00213-007-0992-8. Epub 2007 Nov 18.
9
Reduced binding of [3H]ketanserin to cortical 5-ht2 receptors in senile dementia of the Alzheimer type.在阿尔茨海默型老年痴呆症中,[3H]酮色林与皮质5-羟色胺2受体的结合减少。
Neurosci Lett. 1984 Jan 27;44(1):47-51. doi: 10.1016/0304-3940(84)90219-2.
10
Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia.阿尔茨海默型痴呆患者死后大脑中生物胺及其代谢产物的变化。
J Neurochem. 1984 Aug;43(2):388-93. doi: 10.1111/j.1471-4159.1984.tb00913.x.

引用本文的文献

1
Dysregulated brain-gut axis in the setting of traumatic brain injury: review of mechanisms and anti-inflammatory pharmacotherapies.创伤性脑损伤背景下失调的脑-肠轴:机制和抗炎药物治疗的综述。
J Neuroinflammation. 2024 May 10;21(1):124. doi: 10.1186/s12974-024-03118-3.
2
Decreased 5-HT binding in mild Alzheimer's disease-A positron emission tomography study.轻度阿尔茨海默病患者 5-HT 结合减少:一项正电子发射断层扫描研究。
Synapse. 2022 Jun;76(7-8):e22235. doi: 10.1002/syn.22235. Epub 2022 May 28.
3
Medicinal Cannabis and Central Nervous System Disorders.
药用大麻与中枢神经系统疾病
Front Pharmacol. 2022 Apr 21;13:881810. doi: 10.3389/fphar.2022.881810. eCollection 2022.
4
Dementia-related psychosis and the potential role for pimavanserin.与痴呆相关的精神病和 pimavanserin 的潜在作用。
CNS Spectr. 2022 Feb;27(1):7-15. doi: 10.1017/S1092852920001765. Epub 2020 Aug 19.
5
Behavioural Phenotyping of APPswe/PS1δE9 Mice: Age-Rrelated Changes and Effect of Long-Term Paroxetine Treatment.APPswe/PS1δE9小鼠的行为表型分析:与年龄相关的变化及长期帕罗西汀治疗的影响
PLoS One. 2016 Nov 4;11(11):e0165144. doi: 10.1371/journal.pone.0165144. eCollection 2016.
6
Metabolic changes over the course of aging in a mouse model of tau deposition.tau蛋白沉积小鼠模型衰老过程中的代谢变化。
Neurobiol Aging. 2016 Aug;44:62-73. doi: 10.1016/j.neurobiolaging.2016.04.013. Epub 2016 Apr 25.
7
Impaired satiation and increased feeding behaviour in the triple-transgenic Alzheimer's disease mouse model.三转基因阿尔茨海默病小鼠模型中饱食受损和摄食行为增加。
PLoS One. 2012;7(10):e45179. doi: 10.1371/journal.pone.0045179. Epub 2012 Oct 4.
8
Disturbed neurotransmitter transporter expression in Alzheimer's disease brain.阿尔茨海默病脑中神经递质转运体表达紊乱。
J Alzheimers Dis. 2011;26(4):755-766. doi: 10.3233/JAD-2011-110002.
9
An immunohistochemical study of the serotonin 1A receptor in the hippocampus of subjects with Alzheimer's disease.阿尔茨海默病患者海马体中 5-羟色胺 1A 受体的免疫组织化学研究。
Neuropathology. 2011 Oct;31(5):503-9. doi: 10.1111/j.1440-1789.2010.01193.x. Epub 2011 Jan 27.
10
Differential involvement of hippocampal serotonin1A receptors and re-uptake sites in non-cognitive behaviors of Alzheimer's disease.海马体 5-羟色胺 1A 受体和再摄取位点在阿尔茨海默病非认知行为中的差异参与。
Psychopharmacology (Berl). 2011 Feb;213(2-3):431-9. doi: 10.1007/s00213-010-1936-2. Epub 2010 Jul 13.